Cargando…
Defining the human kidney N‐glycome in normal and cancer tissues using MALDI imaging mass spectrometry
Clear‐cell renal cell carcinoma (ccRCC) presents challenges to clinical management because of late‐stage detection, treatment resistance, and frequent disease recurrence. Metabolically, ccRCC has a well‐described Warburg effect utilization of glucose, but how this affects complex carbohydrate synthe...
Autores principales: | Drake, Richard R., McDowell, Colin, West, Connor, David, Fred, Powers, Thomas W., Nowling, Tamara, Bruner, Evelyn, Mehta, Anand S., Angel, Peggi M., Marlow, Laura A., Tun, Han W., Copland, John A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187388/ https://www.ncbi.nlm.nih.gov/pubmed/31860772 http://dx.doi.org/10.1002/jms.4490 |
Ejemplares similares
-
Imaging Mass Spectrometry and Lectin Analysis of N-Linked Glycans in Carbohydrate Antigen–Defined Pancreatic Cancer Tissues
por: McDowell, Colin T., et al.
Publicado: (2020) -
Bioorthogonal
Chemical Labeling Probes Targeting Sialic
Acid Isomers for N-Glycan MALDI Imaging Mass
Spectrometry of Tissues, Cells, and Biofluids
por: Lu, Xiaowei, et al.
Publicado: (2023) -
Two-Dimensional N-Glycan Distribution Mapping of Hepatocellular Carcinoma Tissues by MALDI-Imaging Mass Spectrometry
por: Powers, Thomas W., et al.
Publicado: (2015) -
Integrating age, BMI, and serum N-glycans detected by MALDI mass spectrometry to classify suspicious mammogram findings as benign lesions or breast cancer
por: Blaschke, Calvin R. K., et al.
Publicado: (2022) -
Glycomics using mass spectrometry
por: Wuhrer, Manfred
Publicado: (2012)